Phase II trial of MVA 5T4 [TroVax] in combination with interferon alpha in patients with metastatic renal cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2008
At a glance
- Drugs Interferon alpha; MVA 5T4
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Oxford BioMedica; Sanofi
- 15 Jun 2008 New trial record.
- 02 Jun 2008 Trial results reported at American Society of Clinical Oncology annual meeting in 2008.